filings.toolsItem 1A. Risk Factors
3K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes in the Company’s risk factors from those disclosed in "Risk Factors" in our 2024 Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table provides information about our purchases during the three months ended September 30, 2025, of equity securities that are registered by us pursuant to Section 12 of the Exchange Act.
| Total Number of Shares Purchased (in 000's) | Average Price Paid per Share (1) | Total Number of Shares Purchased as Part of a Publicly Announced Program (in 000's) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions) | |||||||||||||||||||||||
| 2025 | ||||||||||||||||||||||||||
| July 1 - July 31 | 1,729 | $ | 69.81 | 1,729 | $ | 1,173 | ||||||||||||||||||||
| August 1 - August 31 | 1,541 | $ | 66.56 | 1,541 | $ | 1,071 | ||||||||||||||||||||
| September 1 - September 30 | 4,232 | $ | 61.43 | 4,232 | $ | 811 | ||||||||||||||||||||
| Total | 7,502 | $ | 64.42 | 7,502 | ||||||||||||||||||||||
(1) Excludes broker commissions.
We may purchase our outstanding common stock from time to time subject to market conditions and at our discretion. Repurchases occur in the open market or through one or more other public or private transactions pursuant to plans complying with Rules 10b5-1 and 10b-18 under the Exchange Act. Since the initial authorization in February 2021, the Company's Board of Directors authorized the repurchase of up to $7.1 billion of the Company's outstanding common stock. In October 2025, the Company's Board of Directors approved a $5 billion increase to the Company's existing share repurchase program.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information